Med-Chemist

Med-Chemist : "Quintessential Medicinal Chemistry"

Showing posts with label ovarian cancer. Show all posts
Showing posts with label ovarian cancer. Show all posts
Tuesday, October 8, 2024

FDA Approves Tepylute (thiotepa) Ready-to-Dilute Injectable Formulation to Treat Breast Cancer and Ovarian Cancer

›
Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA...
Friday, November 15, 2013

Combination of heat, doxorubicin drug and nanotech system may improve ovarian cancer treatment

›
The combination of heat, chemotherapeutic drugs and an innovative delivery system based on nanotechnology may significantly improve the tr...
Tuesday, December 20, 2011

Drug Duo of Ixabepilone and sunitinib Kills Chemotherapy-resistant Ovarian Cancer Cells......

›
In continuation of Sunitinib ... The use of two drugs never tried in combination before in ovarian cancer resulted in a 70 percent des...
Thursday, December 9, 2010

New mechanism breaks drug resistance in ovarian cancer

›
New mechanism breaks drug resistance in ovarian cancer
›
Home
View web version

Contributors

  • Dr. Umesh..
  • https://www.med-chemist.com
Powered by Blogger.